NASDAQ:DYAI Dyadic International (DYAI) Stock Price, News & Analysis $0.97 +0.03 (+2.88%) Closing price 04:00 PM EasternExtended Trading$0.96 0.00 (-0.27%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Dyadic International Stock (NASDAQ:DYAI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Dyadic International alerts:Sign Up Key Stats Today's Range$0.94▼$0.9850-Day Range$0.68▼$1.0252-Week Range$0.65▼$1.35Volume45,087 shsAverage Volume164,774 shsMarket Capitalization$35.26 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingHold Company Overview Dyadic International, Inc. is a biotechnology company headquartered in Jupiter, Florida, that specializes in developing and commercializing its proprietary C1 fungal-based expression platform. The company’s core business revolves around enabling efficient, scalable production of proteins and enzymes for a wide range of applications, including biopharmaceuticals, industrial enzymes, agricultural bioactives and biofuels. By leveraging its C1 system, Dyadic seeks to offer clients cost-effective, high-yield manufacturing processes that can accelerate development timelines and reduce overall production costs. The Dyadic C1 platform is designed to produce complex proteins five to ten times faster than traditional cell culture technologies, such as CHO cells or yeast. This enhanced productivity makes the system particularly attractive for contract development and manufacturing organizations (CDMOs), pharmaceutical companies and industrial partners looking to optimize yields of monoclonal antibodies, vaccine antigens, therapeutic enzymes and specialty proteins. Beyond human health, Dyadic pursues collaborations in animal health, nutraceuticals and sustainability sectors, where its fermentation-based approach can be applied to next-generation bioactive ingredients and environmentally friendly enzyme solutions. Since its inception, Dyadic has pursued a model centered on technology partnerships and licensing arrangements to extend the reach of its C1 platform across global markets. The company went public on the Nasdaq exchange under the symbol DYAI and has since established research and commercial alliances in North America, Europe and Asia. Dyadic’s management team comprises experienced biotechnology and industrial fermentation professionals, guiding the company’s strategy to expand its applications pipeline and secure partnerships with leading biomanufacturers and specialty chemical producers worldwide.AI Generated. May Contain Errors. Read More Dyadic International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreDYAI MarketRank™: Dyadic International scored higher than 48% of companies evaluated by MarketBeat, and ranked 469th out of 850 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingDyadic International has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialDyadic International has a consensus price target of $3.00, representing about 209.9% upside from its current price of $0.97.Amount of Analyst CoverageDyadic International has only been the subject of 1 research reports in the past 90 days.Read more about Dyadic International's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Dyadic International are expected to decrease in the coming year, from $0.13 to ($0.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Dyadic International is -4.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Dyadic International is -4.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDyadic International has a P/B Ratio of 32.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Dyadic International's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.51% of the float of Dyadic International has been sold short.Short Interest Ratio / Days to CoverDyadic International has a short interest ratio ("days to cover") of 0.79, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Dyadic International has recently decreased by 76.17%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDyadic International does not currently pay a dividend.Dividend GrowthDyadic International does not have a long track record of dividend growth. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 7 news articles for Dyadic International this week, compared to 3 articles on an average week.Search Interest1 people have searched for DYAI on MarketBeat in the last 30 days. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Dyadic International insiders have not sold or bought any company stock.Percentage Held by Insiders20.90% of the stock of Dyadic International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions27.95% of the stock of Dyadic International is held by institutions.Read more about Dyadic International's insider trading history. Receive DYAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dyadic International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DYAI Stock News HeadlinesDyadic Expands IP Protection and Business Development Activities in JapanJune 29, 2026 | globenewswire.comDyadic International (NASDAQ:DYAI) Stock Price Passes Below Fifty Day Moving Average - Here's What HappenedJune 27, 2026 | americanbankingnews.comSell Tesla, Buy the New King of FSD CarsIn 2023, Marc Chaikin's system flagged an automotive stock as bearish - and it fell 35% shortly after. Today, that same stock has earned a 'Very Bullish' rating after forming a major partnership with Nvidia to power AI-driven autonomous vehicles. This barely-known company was selected to handle the complex job of getting Nvidia's self-driving AI safely inside vehicles - positioning it at the center of a massive trend most investors are still missing through Tesla.July 6 at 1:00 AM | Chaikin Analytics (Ad)Dyadic Shareholders Approve Reverse Split and Governance ProposalsJune 22, 2026 | tipranks.comDyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial AdoptionJune 15, 2026 | globenewswire.comDyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine DevelopmentMay 28, 2026 | globenewswire.comDyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026May 21, 2026 | globenewswire.comSkyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ETMay 21, 2026 | globenewswire.comSee More Headlines DYAI Stock Analysis - Frequently Asked Questions How have DYAI shares performed this year? Dyadic International's stock was trading at $0.94 at the beginning of 2026. Since then, DYAI shares have increased by 1.9% and is now trading at $0.9580. How were Dyadic International's earnings last quarter? Dyadic International Inc. (NASDAQ:DYAI) released its earnings results on Wednesday, May, 13th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.01. The biotechnology company had revenue of $1.11 million for the quarter, compared to the consensus estimate of $0.90 million. Dyadic International had a negative trailing twelve-month return on equity of 1,005.45% and a negative net margin of 192.40%. Read the conference call transcript. How do I buy shares of Dyadic International? Shares of DYAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Dyadic International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dyadic International investors own include Pfizer (PFE), Enbridge (ENB), Meta Platforms (META), Silvercorp Metals (SVM), Endeavour Silver (EXK), Hecla Mining (HL) and Advanced Micro Devices (AMD). Company Calendar Last Earnings5/13/2026Today7/06/2026Next Earnings (Estimated)8/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6d) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 For the last 6 days, DYAI's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:DYAI CIK1213809 Webwww.dyadic.com Phone(561) 743-8333Fax561-743-8343Employees7Year Founded1979Price Target and Rating Average Price Target for Dyadic International$3.00 High Price Target$3.00 Low Price Target$3.00 Potential Upside/Downside+210.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.23) Trailing P/E RatioN/A Forward P/E Ratio7.44 P/E GrowthN/ANet Income-$7.36 million Net Margins-192.40% Pretax Margin-192.40% Return on Equity-1,005.45% Return on Assets-77.64% Debt Debt-to-Equity Ratio4.08 Current Ratio2.42 Quick Ratio2.42 Sales & Book Value Annual Sales$3.09 million Price / Sales11.41 Cash FlowN/A Price / Cash FlowN/A Book Value$0.03 per share Price / Book32.25Miscellaneous Outstanding Shares36,440,000Free Float28,823,000Market Cap$35.26 million OptionableOptionable Beta1.15 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:DYAI) was last updated on 7/6/2026 by MarketBeat.com Staff. From Our PartnersThree companies about to leapfrog Nvidia [And transform the entire industry]The government just committed $200 billion to building computer chips on American soil - one of the largest te...Eagle Publishing | SponsoredAre you leaving Social Security money on the table?Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....Money Pickle | SponsoredAmazon, Google, Meta, and Microsoft just committed $700 billionAmazon, Google, Meta, and Microsoft have committed $700 billion to AI infrastructure in 2026 alone - more than...True Market Insiders | SponsoredIf You Have $50k+ on Coinbase, This Will Ruin Your DayI spent two years reverse-engineering BlackRock's exact playbook. The same framework that generates them $16.1...Decentralized Masters | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredThe Warsh Fed and what it could mean for your savingsThe Fed just changed hands, and Reagan Gold Group says there may be a short window before the impact shows up ...Reagan Gold Group | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyadic International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
